Investigational New Drug (IND) Programs
Source: Charles River
Learn through our years of IND research experience, unique range of services and best-in-class expertise how we can help you successfully initiate and complete your IND-enabling program.
Access the Source℠
- IND Gantt charts for large and small molecules
- Recorded webinar on planning your IND
With our ongoing efforts to improve upon our internal processes and continued focus on scientific excellence and guidance, we are pleased to offer a highly cost-effective IND program for our clients.
We offer a fully compiled, audited draft report at 10 weeks post-necropsy for studies up to and including 13 weeks of treatment across all Charles River preclinical facilities.
This website uses cookies to ensure you get the best experience on our website. Learn more